BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
53 hedge funds and large institutions have $34.8M invested in Baudax Bio, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+53
Holders Change %
–
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
53
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
CCM
Corsair Capital Management
New York
|
+$5.68M |
2 |
BlackRock
New York
|
+$3.56M |
3 |
ECM
Engine Capital Management
New York
|
+$3.06M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.62M |
5 |
Renaissance Technologies
New York
|
+$2.02M |
Top Sellers
No sellers this quarter